| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | postsynapse | 2.82e-05 | 1018 | 20 | 7 | GO:0098794 | |
| GeneOntologyCellularComponent | dendritic spine | 7.34e-05 | 242 | 20 | 4 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 7.94e-05 | 247 | 20 | 4 | GO:0044309 | |
| GeneOntologyCellularComponent | neuromuscular junction | 1.60e-04 | 112 | 20 | 3 | GO:0031594 | |
| GeneOntologyCellularComponent | cholinergic synapse | 1.99e-04 | 22 | 20 | 2 | GO:0098981 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 5.26e-04 | 405 | 20 | 4 | GO:0045211 | |
| GeneOntologyCellularComponent | dendrite | 1.07e-03 | 858 | 20 | 5 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 1.08e-03 | 860 | 20 | 5 | GO:0097447 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.18e-03 | 503 | 20 | 4 | GO:0099572 | |
| GeneOntologyCellularComponent | synaptic membrane | 2.03e-03 | 583 | 20 | 4 | GO:0097060 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 5.13e-03 | 1228 | 20 | 5 | GO:0036477 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 6.80e-03 | 817 | 20 | 4 | GO:0098978 | |
| Domain | C2 | 9.40e-03 | 131 | 21 | 2 | PF00168 | |
| Domain | C2 | 1.02e-02 | 137 | 21 | 2 | SM00239 | |
| Domain | C2 | 1.10e-02 | 142 | 21 | 2 | PS50004 | |
| Domain | - | 1.19e-02 | 148 | 21 | 2 | 2.60.40.150 | |
| Pubmed | The protomap is propagated to cortical plate neurons through an Eomes-dependent intermediate map. | 2.45e-05 | 94 | 21 | 3 | 23431145 | |
| Pubmed | Biological insights from 108 schizophrenia-associated genetic loci. | 3.01e-05 | 303 | 21 | 4 | 25056061 | |
| Pubmed | Differential gene expression in migratory streams of cortical interneurons. | 3.15e-05 | 14 | 21 | 2 | 22103416 | |
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 3.82e-05 | 109 | 21 | 3 | 33554859 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q24 | 1.53e-02 | 415 | 21 | 2 | chr12q24 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 7.23e-03 | 181 | 13 | 2 | 694 | |
| CoexpressionAtlas | BM Top 100 - occipital lobe | 4.96e-05 | 73 | 21 | 3 | BM Top 100 - occipital lobe | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.75e-07 | 155 | 21 | 4 | cba6f3f7742b4d5d54ad0a0ac0dd4016e73fe658 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.83e-05 | 110 | 21 | 3 | bc1986e5a496a4d25da3445b6f252f81741619f4 | |
| ToppCell | PBMC-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 5.60e-05 | 160 | 21 | 3 | 4dac64e58d9366c399f3d830848ccb720d400be7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 165 | 21 | 3 | e2aebb2fe197151e019371b8960f76f0c2386f08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 165 | 21 | 3 | b087771499aeb31cc4a338d2d0a9392a4ec1ac45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 165 | 21 | 3 | d8f8b088fd28a6b9dbd6b51bcaee42000e963321 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 166 | 21 | 3 | ec7bd549bda5f18aca8aebce5ba479a81abbbeda | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.82e-05 | 171 | 21 | 3 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | facs-Skin-nan-24m-Lymphocytic-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 174 | 21 | 3 | 6863222bec844f40c0c80f5c82a8ff51d1a56d0a | |
| ToppCell | facs-Skin-nan-24m-Lymphocytic-T_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 174 | 21 | 3 | d570eab215f8287362084e37f35672e20aa0f7a2 | |
| ToppCell | facs-Skin-nan-24m-Lymphocytic|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 174 | 21 | 3 | 5739c1b8d643ad360ef32049832d749c530ca603 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.18e-05 | 174 | 21 | 3 | a5f2a4e3b25e6084bd7003a53da86a44f6fcf294 | |
| ToppCell | COVID-19-Myeloid-MoAM4|COVID-19 / Condition, Lineage and Cell class | 7.56e-05 | 177 | 21 | 3 | ca5d0c3d5c700bbe4c2da068eb02be6229afb9a0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.56e-05 | 177 | 21 | 3 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.81e-05 | 179 | 21 | 3 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-05 | 179 | 21 | 3 | 08cf9986804a6417a9afb19b50c69a3554f71ec6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.81e-05 | 179 | 21 | 3 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.94e-05 | 180 | 21 | 3 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.07e-05 | 181 | 21 | 3 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_B-Naive_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 8.34e-05 | 183 | 21 | 3 | be294d22b91dbcf1e8d22e6a31c39b5caaad4751 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.34e-05 | 183 | 21 | 3 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.61e-05 | 185 | 21 | 3 | 739260f8abebaf10a5cc49d91726278579e26170 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.75e-05 | 186 | 21 | 3 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 9.03e-05 | 188 | 21 | 3 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 9.32e-05 | 190 | 21 | 3 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron|World / Primary Cells by Cluster | 9.47e-05 | 191 | 21 | 3 | 4dd9c8117c4499ed9bde127baf2598603a82080d | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1|World / Primary Cells by Cluster | 9.62e-05 | 192 | 21 | 3 | bcc499f4c7ba2898ecd9c47bf68c92ed359b81ba | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.76e-05 | 193 | 21 | 3 | 456aa8a8f1f9cbba0bd618a5f623909079c0f56b | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-Naive_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue | 9.91e-05 | 194 | 21 | 3 | 20967afbadb3cf80ba9f4d7ebda4e64389252e70 | |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.91e-05 | 194 | 21 | 3 | 660535b492445063d965095a50e1e299ce04c50a | |
| ToppCell | myeloid-Monocyte-CD14+_Monocyte|myeloid / Lineage, cell class and subclass | 1.01e-04 | 195 | 21 | 3 | 15ba9c5f6ecb6ae2c603e6b036eb92b00b46f13f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 195 | 21 | 3 | 23ced69fd904f1d4114b1a7f99f4b5f65ea8824b | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 196 | 21 | 3 | 97324c9e93f833e1f218e81fb53066d44c6892df | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.02e-04 | 196 | 21 | 3 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.02e-04 | 196 | 21 | 3 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 1.04e-04 | 197 | 21 | 3 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 198 | 21 | 3 | 1378c6d4ceb84b42fdd6556be3296df7a8059e6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 198 | 21 | 3 | 451003a21162eeae90739fdb502bb50b362d80c8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 198 | 21 | 3 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 198 | 21 | 3 | 440af8f90c7afa1c07000806bcf9110b70f489fb | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 199 | 21 | 3 | 5d976d57872a8a25a11fe8cd53b01aa21a1a519a | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-04 | 199 | 21 | 3 | 14e09eaa2335d4503de50250eb4258dd5b85b304 | |
| ToppCell | COVID-19-kidney-Glomerular_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.07e-04 | 199 | 21 | 3 | fffd2f9042b55531dac4e5b463b5cee80402e7bb | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Cortical_neuron|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-04 | 200 | 21 | 3 | 7bba2ff09349c8db3d1ccf53520b12cbf7b0abac | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-04 | 200 | 21 | 3 | 306926cb7a847871641f02e03d52dc56fd55711c | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 200 | 21 | 3 | 3007583eaad3a5ae2df010513d3e4df59155123d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-04 | 200 | 21 | 3 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.08e-04 | 200 | 21 | 3 | 6beabd5bad042d4d65c89c2f537c7376230f7c08 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.08e-04 | 200 | 21 | 3 | 026495aa7f1e7528a01d9199475cfc393677fc60 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 200 | 21 | 3 | 9f1626a7e1bd00977a5c316cafbdf654b52bad94 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-04 | 200 | 21 | 3 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Interneuron|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.98e-04 | 63 | 21 | 2 | c10d344bf32a091deb79e1f128f7dd5e9f4abaa3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 5.49e-04 | 74 | 21 | 2 | a50df7f4f7847b8aeff3fc6d521a69b50e05c719 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal-GABAergic_neurons|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 7.75e-04 | 88 | 21 | 2 | 5582fd7bac60c690ecd1f2aff1d446ccb69f79b9 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.29e-04 | 91 | 21 | 2 | b0658e020f80e56fab9d2aa07e321d9b33d7af2c | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.14e-03 | 107 | 21 | 2 | fb06b39b0f1bcb8fc8ae8ebbf2b30d6f90a1839a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Interneuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.46e-03 | 121 | 21 | 2 | b2d571f571133c281d72584fe925cebbd2317829 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.46e-03 | 121 | 21 | 2 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | RA-12._Cytoplasmic_Cardiomyocyte_II|RA / Chamber and Cluster_Paper | 1.68e-03 | 130 | 21 | 2 | 314da0b9f24473e1f4e51e884c1768f23a95ba79 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.70e-03 | 131 | 21 | 2 | 1823cab28fab40486247ca92104267b1e370bdc1 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.78e-03 | 134 | 21 | 2 | 8707210b2a5d33baa1d204e9e2ed8921181cb309 | |
| ToppCell | RA-12._Cytoplasmic_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.78e-03 | 134 | 21 | 2 | 88795b2079c0909308ec4bf7eafd3e01f5cdd8da | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-03 | 136 | 21 | 2 | 186be8e1595608004b8216892cb9c7a7f31fbb4d | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.91e-03 | 139 | 21 | 2 | 693ca81f5831b63fe6148ac755631e09f67d0ebf | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-cortical_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.97e-03 | 141 | 21 | 2 | 73b3e967357cba7585d97ec9e9d48d3e94ebe31e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.05e-03 | 144 | 21 | 2 | 7de962346ba9653d90dd13bb7d977fe44d200bba | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-03 | 145 | 21 | 2 | 4f8b188a93a038afbc7a446df8467ad544f5b1cb | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.08e-03 | 145 | 21 | 2 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.14e-03 | 147 | 21 | 2 | 50e86860a94be103092c40e39a172eac92372f0d | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-03 | 148 | 21 | 2 | 74f1f9d1a53dc1a09cb6a504cbbdc7496c5b6879 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.17e-03 | 148 | 21 | 2 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.20e-03 | 149 | 21 | 2 | 3378d0fe79de6d7879fd48717ded5027593c785f | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-03 | 149 | 21 | 2 | 4de52569611e63a780cde9bd111d6d9c11a05a11 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-03 | 149 | 21 | 2 | c957ac23ad6343eacce7e6be4a6d3ac043af4f86 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-03 | 150 | 21 | 2 | 8645b9c7f9511ed6cc9afe04440c2873a3094150 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.22e-03 | 150 | 21 | 2 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.22e-03 | 150 | 21 | 2 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-03 | 152 | 21 | 2 | 87a7116d0064a6051bdf28ce1e48bfc168273e66 | |
| ToppCell | COVID-19_Severe-multiplets|COVID-19_Severe / disease group, cell group and cell class | 2.28e-03 | 152 | 21 | 2 | 451745151322c2fcea22dbb3dba681e12634a510 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.28e-03 | 152 | 21 | 2 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.34e-03 | 154 | 21 | 2 | 020697ae8463b18f9b4270c404f52ce4c0e90135 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-03 | 154 | 21 | 2 | 46155f36d3983f637b55d7525b675c8828f6ab2e | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-03 | 154 | 21 | 2 | 71ffc23a2e02e27cabbdbeaa622e59e9f4a4cd9d | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.37e-03 | 155 | 21 | 2 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-03 | 155 | 21 | 2 | 4559e3011514041b65c17ae4ede29da202bce14c | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-03 | 155 | 21 | 2 | 77ae0b8d30bc3db4a73fd5340f99691a73d2684f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.37e-03 | 155 | 21 | 2 | d10cf5e922dbd3ca46660404da5aca43f181fc19 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.37e-03 | 155 | 21 | 2 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.37e-03 | 155 | 21 | 2 | 99e749f7075e2c64e9a0bf91009f95b6969197c8 | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte-neutrophil__Lgals3-negative|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.40e-03 | 156 | 21 | 2 | 166f7b1220eaf8e1149dde260dd85a094855c54f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.40e-03 | 156 | 21 | 2 | 7569cab30caafcb273e8ef0b73c9e1bf87076984 | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.40e-03 | 156 | 21 | 2 | 5e1c5a7c9293b886920739cf766521df7f69726c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.43e-03 | 157 | 21 | 2 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.46e-03 | 158 | 21 | 2 | 7274f020c0ecf216da4b6689c62bc5f49c29b6f3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-03 | 159 | 21 | 2 | fd7db2f7328cfefdc3ada2af91006d5a91d137e1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-03 | 159 | 21 | 2 | d3f81ba22160568ccaa6d2b04ebfd30630f9a6db | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-03 | 159 | 21 | 2 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.49e-03 | 159 | 21 | 2 | bf8ff9251bcb64b2b9d6dd93461aec97659686ec | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.49e-03 | 159 | 21 | 2 | 235ed12053b337aca5abc2ce8727332b4ae3f8ae | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.49e-03 | 159 | 21 | 2 | 7f29f9dcf25ffa1822b137c571e9ac16defc6292 | |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; HL60; HT_HG-U133A | 2.68e-05 | 193 | 21 | 4 | 1297_DN | |
| Drug | Pipemidic acid [51940-44-4]; Down 200; 13.2uM; HL60; HT_HG-U133A | 2.84e-05 | 196 | 21 | 4 | 3093_DN | |
| Drug | Vinpocetine [42971-09-5]; Down 200; 11.4uM; HL60; HG-U133A | 3.02e-05 | 199 | 21 | 4 | 1557_DN | |
| Drug | Buspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; HL60; HT_HG-U133A | 3.08e-05 | 200 | 21 | 4 | 1282_DN | |
| Drug | Flavonoids | 4.32e-04 | 1136 | 21 | 6 | ctd:D005419 | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | 5.91e-04 | 181 | 21 | 3 | 1791_DN | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 6.60e-04 | 188 | 21 | 3 | 1177_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; HL60; HT_HG-U133A | 6.60e-04 | 188 | 21 | 3 | 1150_UP | |
| Drug | thioridazine hydrochloride; Down 200; 10uM; HL60; HT_HG-U133A | 6.71e-04 | 189 | 21 | 3 | 1171_DN | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 7.02e-04 | 192 | 21 | 3 | 2699_DN | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A | 7.23e-04 | 194 | 21 | 3 | 3807_DN | |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; HL60; HT_HG-U133A | 7.23e-04 | 194 | 21 | 3 | 3035_DN | |
| Drug | Carbarsone [121-59-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 7.23e-04 | 194 | 21 | 3 | 4110_UP | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; HL60; HT_HG-U133A | 7.23e-04 | 194 | 21 | 3 | 1856_DN | |
| Drug | Cephalothin sodium salt [58-71-9]; Down 200; 9.6uM; HL60; HT_HG-U133A | 7.34e-04 | 195 | 21 | 3 | 2517_DN | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; HL60; HG-U133A | 7.34e-04 | 195 | 21 | 3 | 1984_DN | |
| Drug | Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; HL60; HT_HG-U133A | 7.34e-04 | 195 | 21 | 3 | 1273_UP | |
| Drug | Spironolactone [52-01-7]; Up 200; 9.6uM; PC3; HT_HG-U133A | 7.34e-04 | 195 | 21 | 3 | 2064_UP | |
| Drug | Hesperidin [520-26-3]; Down 200; 6.6uM; HL60; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 1294_DN | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; PC3; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 7155_UP | |
| Drug | radicicol; Up 200; 0.1uM; MCF7; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 5947_UP | |
| Drug | Oxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 6309_DN | |
| Drug | Naloxone hydrochloride [357-08-4]; Down 200; 11uM; PC3; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 4645_DN | |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 5063_DN | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; HL60; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 2207_UP | |
| Drug | Fluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; HL60; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 3032_DN | |
| Drug | Methimazole [60-56-0]; Up 200; 35uM; MCF7; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 4372_UP | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 3618_DN | |
| Drug | Cefotetan [69712-56-7]; Up 200; 7uM; MCF7; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 4116_UP | |
| Drug | Pindolol [13523-86-9]; Up 200; 16.2uM; PC3; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 2075_UP | |
| Drug | Orlistat; Up 200; 10uM; MCF7; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 6383_UP | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; HL60; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 2569_DN | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 2641_UP | |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; PC3; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 2124_DN | |
| Drug | clozapine; Up 200; 10uM; HL60; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 2689_UP | |
| Drug | Piperine [94-62-2]; Up 200; 14uM; HL60; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 1327_UP | |
| Drug | STOCK1N-35696; Down 200; 15uM; MCF7; HT_HG-U133A | 7.56e-04 | 197 | 21 | 3 | 6577_DN | |
| Drug | Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; HL60; HG-U133A | 7.68e-04 | 198 | 21 | 3 | 1583_DN | |
| Drug | Urosiol [128-13-2]; Down 200; 10.2uM; PC3; HT_HG-U133A | 7.68e-04 | 198 | 21 | 3 | 7243_DN | |
| Drug | flufenamic acid; Up 200; 10uM; MCF7; HG-U133A | 7.68e-04 | 198 | 21 | 3 | 316_UP | |
| Drug | Paroxetine maleate [64006-44-6]; Up 200; 1uM; MCF7; HT_HG-U133A | 7.68e-04 | 198 | 21 | 3 | 4378_UP | |
| Drug | Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; HL60; HT_HG-U133A | 7.79e-04 | 199 | 21 | 3 | 2198_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; HL60; HT_HG-U133A | 7.79e-04 | 199 | 21 | 3 | 2546_DN | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 7.79e-04 | 199 | 21 | 3 | 6069_UP | |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; HL60; HG-U133A | 7.79e-04 | 199 | 21 | 3 | 2039_UP | |
| Drug | Cefoperazone dihydrate; Down 200; 5.8uM; HL60; HG-U133A | 7.79e-04 | 199 | 21 | 3 | 1627_DN | |
| Drug | Ungerine nitrate; Up 200; 10.2uM; MCF7; HT_HG-U133A | 7.79e-04 | 199 | 21 | 3 | 6076_UP | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; PC3; HG-U133A | 7.90e-04 | 200 | 21 | 3 | 1920_DN | |
| Drug | Delsoline [509-18-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 7.90e-04 | 200 | 21 | 3 | 6075_UP | |
| Disease | pulse pressure measurement | 2.39e-04 | 1392 | 20 | 6 | EFO_0005763 | |
| Disease | attention deficit hyperactivity disorder, bipolar disorder, autism spectrum disorder, schizophrenia, major depressive disorder | 5.46e-04 | 51 | 20 | 2 | EFO_0003756, EFO_0003888, MONDO_0002009, MONDO_0004985, MONDO_0005090 | |
| Disease | hair colour measurement | 6.94e-04 | 615 | 20 | 4 | EFO_0007822 | |
| Disease | post-traumatic stress disorder symptom measurement | 1.40e-03 | 82 | 20 | 2 | EFO_0008535 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 2.12e-03 | 101 | 20 | 2 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | corneal endothelial cell measurement | 2.42e-03 | 108 | 20 | 2 | EFO_0010079 | |
| Disease | Malignant neoplasm of liver | 4.13e-03 | 142 | 20 | 2 | C0345904 | |
| Disease | Liver neoplasms | 4.13e-03 | 142 | 20 | 2 | C0023903 | |
| Disease | age at onset, Myopia | 4.59e-03 | 150 | 20 | 2 | EFO_0004847, HP_0000545 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.71e-03 | 152 | 20 | 2 | DOID:0060041 (implicated_via_orthology) | |
| Disease | colorectal cancer, colorectal adenoma | 4.71e-03 | 152 | 20 | 2 | EFO_0005406, MONDO_0005575 | |
| Disease | unipolar depression, bipolar disorder | 4.96e-03 | 156 | 20 | 2 | EFO_0003761, MONDO_0004985 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 8.02e-03 | 200 | 20 | 2 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLHTSGSERSHWEEM | 396 | Q7L8C5 | |
| WTMDAEADHSGGSDR | 561 | Q92667 | |
| HSDWQMDHRASSSGP | 1661 | O14646 | |
| EDDWRSSVPSHSMSS | 696 | Q9Y2H0 | |
| DWSHMRGIISSDGES | 541 | Q9BW71 | |
| FMQDGHHSSDPWSSS | 216 | P15884 | |
| WSDPTPMKADTSHDS | 291 | Q6X4W1 | |
| SHERTGPDDFEWMSD | 496 | O94988 | |
| WTYGDDTTDLSHSRM | 651 | Q16827 | |
| TGSTLDSTMDHWAEG | 3871 | Q4G0P3 | |
| SGSTSAHMPWDEFPS | 436 | P24394 | |
| SDWDSAPETMEDVGH | 41 | O95873 | |
| HLEETWMASPETDSG | 911 | Q7Z591 | |
| MSSSSRDSESWDHSG | 241 | Q9Y2J0 | |
| EVVMEHPSSGSDWSD | 321 | Q93075 | |
| EELHRWSDMSGDSSA | 2861 | Q8NF91 | |
| DDEAWTFRSSDAHGM | 226 | Q9ULZ9 | |
| HDQERGWFPSSMTEE | 656 | Q8N5V2 | |
| DTDDDDDMPHSTSRW | 276 | Q8NG27 | |
| DMSSSDSDSDWDGGS | 71 | Q6ZNR0 | |
| EHDESWDSMPSSSRG | 221 | Q96N77 |